Suchergebnisse - "Bajel, Ashish"

PubPharm (6)

1

A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia

enthalten in: Leukemia research | 2017

von Verstovsek, S. | Courby, S. | Griesshammer, M. | +8

2

A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis

enthalten in: Internal medicine journal | 2017

von Ho, P. | Bajel, A. | Burbury, K. | +5

3

Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy

enthalten in: The Journal of antimicrobial chemotherapy | 2013

von Heng, S. | Slavin, M. | Al-Badriyeh, D. | +7

4

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

enthalten in: Haematologica | 2012

von Ananda-Rajah, M. | Grigg, A. | Downey, M. | +6

5

Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia

enthalten in: The Journal of antimicrobial chemotherapy | 2010

von Al-Badriyeh, D. | Slavin, M. | Liew, D. | +6

6

Safe treatment of a patient with CML using dasatinib after prior retinal oedema due to imatinib

enthalten in: Leukemia research | 2008

von Bajel, A. | Bassili, S. | Seymour, J.

1
[1]